3,3-Difluoropiperidine-4,4-diol hydrochloride
- $45 - $616.32
- Product name: 3,3-Difluoropiperidine-4,4-diol hydrochloride
- CAS: 1788044-01-8
- MF: C5H10ClF2NO2
- MW: 189.59
- EINECS:
- MDL Number:MFCD28502524
- Synonyms:3,3-Difluoropiperidine-4,4-diol hydrochloride;3,3-Difluoro-4,4-piperidinediol Hydrochloride;4,4-piperidinediol, 3,3-difluoro-, hydrochloride;3,3-DIFLUOROPIPERIDINE-4,4-DIOL HCL
4 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
- TRC
Package
- 10mg
- 1g
- ManufacturerAlichem
- Product number1788044018
- Product description3,3-Difluoropiperidine-4,4-diolhydrochloride
- Packaging1g
- Price$616.32
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM294341
- Product description3,3-Difluoropiperidine-4,4-diolhydrochloride 95%
- Packaging1g
- Price$539
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11229246
- Product description3,3-Difluoropiperidine-4,4-diolhydrochloride 95+%
- Packaging1g
- Price$570
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP482733
- Product description3,3-Difluoro-4,4-piperidinediolHydrochloride
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1788044018 | 3,3-Difluoropiperidine-4,4-diolhydrochloride | 1g | $616.32 | 2021-12-16 | Buy |
Chemenu | CM294341 | 3,3-Difluoropiperidine-4,4-diolhydrochloride 95% | 1g | $539 | 2021-12-16 | Buy |
Crysdot | CD11229246 | 3,3-Difluoropiperidine-4,4-diolhydrochloride 95+% | 1g | $570 | 2021-12-16 | Buy |
TRC | P482733 | 3,3-Difluoro-4,4-piperidinediolHydrochloride | 10mg | $45 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|